Mike Zhong

1.6k total citations · 1 hit paper
21 papers, 881 citations indexed

About

Mike Zhong is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Mike Zhong has authored 21 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Mike Zhong's work include Multiple Myeloma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Mike Zhong is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Peptidase Inhibition and Analysis (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Mike Zhong collaborates with scholars based in China, United States and United Kingdom. Mike Zhong's co-authors include Kenneth C. Anderson, Chirag Acharya, Yu‐Tzu Tai, Nikhil C. Munshi, Paul G. Richardson, Antonia Cagnetta, Michele Cea, Gang An, Xiaoyan Feng and Lugui Qiu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Optics Express.

In The Last Decade

Mike Zhong

17 papers receiving 869 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

2014 375 citations Yu‐Tzu Tai, Patrick A. Mayes et al. Blood profile →

Peers

Mike Zhong

ONCOL

HEMAT

RNMI

IMMUN

Daniëlle C.H. Jacobs Netherlands

Marielle Chiron France

Binje Vick Germany

Michael S. van der Veer Netherlands

Heather Kostner United States

Glenn Michelson United States

Sophie Derenne France

Antreas Hindoyan United States

Grégory Ehx Belgium

Daniëlle C.H. Jacobs Netherlands

Mike Zhong

514 ×0.9

ONCOL

562 ×1.1

HEMAT

366 ×1.0

298 ×1.3

RNMI

206 ×1.0

IMMUN

Citations per year, relative to Mike Zhong Mike Zhong (= 1×) peers Daniëlle C.H. Jacobs

Countries citing papers authored by Mike Zhong

Since Specialization

Citations

This map shows the geographic impact of Mike Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Zhong more than expected).

Fields of papers citing papers by Mike Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Zhong. The network helps show where Mike Zhong may publish in the future.

Co-authorship network of co-authors of Mike Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Zhong. A scholar is included among the top collaborators of Mike Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Zhong. Mike Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jiaxi, et al.. (2025). Integrative bioinformatics analysis reveals CGAS as a ferroptosis-related signature gene in sepsis and screens the potential natural inhibitors of CGAS. International Journal of Biological Macromolecules. 297. 139778–139778.

Hou, Yuyang, et al.. (2025). Sperm metabolomic profiles of varicocele-associated asthenozoospermia. Journal of Pharmaceutical and Biomedical Analysis. 263. 116908–116908. 1 indexed citations

Zhong, Mike, Yupeng Wang, Peng Yuan, et al.. (2025). Cordycepin attenuated cyclophosphamide (CTX)-induced immunosuppression in mice via EGFR/Nrf2 antioxidant signaling pathway. International Immunopharmacology. 163. 115235–115235.

Zhang, Qican, et al.. (2025). Multidimensional computed measurement for highly accurate PCBA defect detection. Optics Express. 33(3). 5340–5340.

Sun, Yang, et al.. (2025). Cordycepin extends the longevity of Caenorhabditis elegans via antioxidation and regulation of fatty acid metabolism. European Journal of Pharmacology. 994. 177388–177388. 1 indexed citations

Berchuck, Jacob E., Praful Ravi, Anthony D’Ippolito, et al.. (2025). Plasma epigenomic profiling to reveal molecular correlates of response and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 43(16_suppl). 5074–5074.

Wang, Yupeng, Yanhui Deng, Jiaxi Chen, et al.. (2024). Cordycepin Extracted from Cordyceps militaris mitigated CUMS-induced depression of rats via targeting GSK3β/β-catenin signaling pathway. Journal of Ethnopharmacology. 340. 119249–119249. 2 indexed citations

Zhong, Mike, Yang Zhu, Peipei Pan, et al.. (2024). Effects of parabens on human and rat placental 3β-hydroxysteroid dehydrogenase isoforms: Structure activity relationship and docking analysis. The Journal of Steroid Biochemistry and Molecular Biology. 245. 106638–106638. 1 indexed citations

Hou, Yuyang, Jingjie Wang, Yanfen Zhou, et al.. (2024). Metabolomic signature of sperm in men with obesity-associated asthenozoospermia. Journal of Assisted Reproduction and Genetics. 41(11). 3161–3171. 3 indexed citations

10.

Zhong, Mike, et al.. (2023). Synthesis of Vismodegib Derivatives as Potential Smo Agonist: A Case of Undergraduate Experimental Teaching. Russian Journal of General Chemistry. 93(10). 2694–2707. 1 indexed citations

11.

An, Gang, Chirag Acharya, Xiaoyan Feng, et al.. (2016). Osteoclasts Promote Immune Suppressive Microenvironment in Multiple Myeloma: Therapeutic Implication. Blood. 128(22). 3303–3303. 8 indexed citations

12.

Tai, Yu‐Tzu, Chirag Acharya, Gang An, et al.. (2016). APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment. Blood. 127(25). 3225–3236. 251 indexed citations

13.

An, Gang, Chirag Acharya, Xiaoyan Feng, et al.. (2016). Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication. Blood. 128(12). 1590–1603. 147 indexed citations

14.

Tai, Yu‐Tzu, Chirag Acharya, Gang An, et al.. (2014). A Novel Anti-a Proliferation-Inducing Ligand Hapril.01A Monoclonal Antibody Targets Multiple Myeloma Cells in the Bone Marrow Microenvironment. Blood. 124(21). 2098–2098. 1 indexed citations

15.

Jiang, Hua, Gang An, Chirag Acharya, et al.. (2014). SAR650984 (SAR) Directly Promotes Homotypic Adhesion-Related Multiple Myeloma (MM) Cell Death and SAR-Induced Anti-MM Activities Are Enhanced By Pomalidomide, More Potently Than Lenalidomide. Blood. 124(21). 2124–2124. 2 indexed citations

16.

An, Gang, Hua Jiang, Chirag Acharya, et al.. (2014). SAR 650984, a Therapeutic Anti-CD38 Monoclonal Antibody, Blocks CD38-CD31 Interaction in Multiple Myeloma. Blood. 124(21). 4729–4729. 14 indexed citations

17.

Tai, Yu‐Tzu, Chirag Acharya, Mike Zhong, et al.. (2013). Constitutive B-Cell Maturation Antigen (BCMA) Activation In Human Multiple Myeloma Cells Promotes Myeloma Cell Growth and Survival In The Bone Marrow Microenvironment Via Upregulated MCL-1 and NFκB Signaling. Blood. 122(21). 681–681. 2 indexed citations

18.

Tai, Yu‐Tzu, Chirag Acharya, Mike Zhong, et al.. (2013). Novel Fc-Engineered Anti-B Cell Maturation Antigen-Monomethyl Auristatin F Antibody-Drug Conjugate (GSK2857916) Induces Potent and Selective Anti-Multiple Myeloma Activity Via Enhanced Effector Function and Direct Tumor Cell Killing. Blood. 122(21). 877–877. 2 indexed citations

19.

Cagnetta, Antonia, Michele Cea, Teresa Calimeri, et al.. (2013). Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity. Blood. 122(7). 1243–1255. 68 indexed citations

20.

Acharya, Chirag, Mike Zhong, Yolanda Calle, et al.. (2012). CRM1 Inhibition Abrogates Osteoclast Formation and Bone Resorption Via Inhibition of RANKL-Induced NFκB While Sparing Osteoblastogenesis: Further Therapeutic Implication in Multiple Myeloma. Blood. 120(21). 1835–1835. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact